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Abstract
The effects of thyroid hormone on brain development and function are largely mediated by the binding of 3,5,39-triiodo-L-
thyronine (T3) to its nuclear receptors (TR) to regulate positively or negatively gene expression. We have analyzed by
quantitative polymerase chain reaction the effect of T3 on primary cultured cells from the embryonic mouse cerebral cortex,
on the expression of Hr, Klf9, Shh, Dio3, Aldh1a1, and Aldh1a3. In particular we focused on T3 receptor specificity, and on the
crosstalk between T3, retinoic acid and dexamethasone. To check for receptor subtype specificity we used cerebrocortical
cells derived from wild type mice and from mice deficient in thyroid hormone receptor subtypes. Receptor subtype
specificity was found for Dio3 and Aldh1a1, which were induced by T3 only in cells expressing the T3 receptor alpha 1
subtype. Interactions of T3 with retinoic acid signaling through the control of retinoic acid metabolism are likely to be
important during development. T3 had opposing influences on retinoic acid synthesizing enzymes, increasing the
expression of Aldh1a1, and decreasing Aldh1a3, while increasing the retinoic acid degrading enzyme Cyp26b1.
Dexamethasone increased Klf9 and Aldh1a1 expression. The effects of T3 and dexamethasone on Aldh1a1 were highly
synergistic, with mRNA increments of up to 20 fold. The results provide new data on thyroid hormone regulation of gene
expression and underscore the importance of thyroid hormone interactions with retinoic acid and glucocorticoids during
neural development.
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Introduction
Thyroid hormone action on mammalian brain development is
exerted through regulation of gene expression mediated by
binding of the active hormone T3 to the nuclear receptors
encoded by the THRA/Thra and THRB/Thrb genes [1,2]. The
THRA/Thra gene encodes the T3 binding isoform TRa1, and
several non T3-binding splicing products. The THRB/Thrb gene
encodes the T3 biding isoforms TRb1 and TRb2. The TR
subtypes and isoforms have different but overlapping distribution
in tissues, with distinct roles in development and physiology [3].
Hypothyroidism in rodents during the fetal and neonatal period,
as well as in adult animals leads to increased or decreased
expression of many genes in the cerebral cortex and other brain
regions [4–6]. Expression changes of some of these genes have
been used as sensitive indicators of the impact on the brain of
situations leading to altered metabolism and/or transport of
thyroid hormones, such as inactivation of the deiodinase genes
Dio2 and Dio3, thyroid hormone transporter genes Mct8 and
Oatp1c1, and the receptor genes Thra and Thrb, in addition to hypo
or hyperthyroidism [5–9]. These studies have produced data that
in some cases are difficult to explain, and reflect the complexity of
the physiological mechanisms regulating gene expression in vivo.
For example, inactivation of the Mct8 gene which leads to
restricted entry of T3 through the blood-brain barrier has a limited
effect on cerebral cortex gene expression postnatally. This is due to
up regulation of Dio2 and increased local T3 formation.
Consequently, compound inactivation of Mct8 and Dio2 leads to
a situation more similar to hypothyroidism, but surprisingly some
genes profoundly affected in the hypothyroid brain such as Aldh1a1
are not affected by concomitant Mct8 and Dio2 inactivation [5].
Single inactivation of the Dio2 gene in mice leads to brain T3
concentrations similar to hypothyroidism, but relatively minor
effects on gene expression [10]. More recently it was found that
Dio2 inactivation preferentially affects expression of the genes
regulated negatively by T3 rather than the positively regulated
genes. The latter observation suggests that gene expression is also
dependent on the route of entry of T3 to the brain [5]. Paradoxical
effects of Dio3 inactivation and T3 administration on cortex gene
expression were also found [9]. Positive gene such as Hr, Kcnj10,
Shh, and others were not affected by Dio3 inactivation but were
sensitive to T3-induced hyperthyroidism. In contrast negative
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genes such as Cirbp, Fxyd6, Gpc3, and others were sensitive to Dio3
inactivation but resistant to T3 administration. These results could
not be explained by a simple mechanism of neuronal T3 increase
by decreased degradation in the Dio3KO mice, and indicate that
the source of T3 is also important.
On the other hand, single or compound inactivation of the
mouse Thra and Thrb genes leads to mild perturbations of gene
expression compared to hypothyroidism. In a recent study [6] we
found that from 27 cortex and striatal genes which expression was
reduced by hypothyroidism only around 10 were reduced by
TRa1 deficiency and 6 were increased by TRb deficiency.
Inactivation of both receptor genes increased the number of
affected genes to 17, and there was no correlation between the
effects of hypothyroidism and the effects of receptor gene
inactivation. In general the conclusion of these studies was that
in the absence of TRa1 thyroid hormone-dependent gene
expression can be largely maintained by TRb, and that the effects
of hypothyroidism are largely due to the transcriptional effects of
unliganded TR.
It is likely that thyroid hormone action on the brain in vivo is
modulated by many interacting physiological factors acting on
micro domains. The bulk effect observed in vivo in individual brain
regions would be an aggregate result of the interaction of T3 with
additional factors that may be modulated differently in each micro
domain, depending on the cellular composition, expression of
receptors, transporters, deiodinases, and the crosstalk with other
signaling pathways. To better understand the role of different
factors in the action of thyroid hormone on neural gene expression
we have analyzed the expression of some selected genes in primary
cultures of mouse cerebrocortical cells. Specifically we studied the
effects of TR knockdown in vivo on the effects of T3 to better
define the relative roles of TRa1 and TRb. In addition we studied
the crosstalk between thyroid hormone and retinoic acid, or
glucocorticoids, as it is known that the effects of these hormonal
systems are frequently interrelated. For example, retinoic acid and
thyroid hormone may regulate the expression of some genes
through similar responsive elements [11–13]. Examples of genes
regulated by T3 and glucocorticoids at the transcriptional level
include GH [14–17], cholesterol 7a-hydrolase [18], liver cytosolic
PEPCK [19], FAS [20], Pdk4 [21], and Klf9 [22], among other
genes.
Materials and Methods
Ethics statement: All experimental procedures involving animals
were performed following the European Union Council guidelines
(directive 2010/63/UE) and Spanish regulations (R.D.1201/2005,
and Law 32/2007). They were approved by the ethics committee
of our institution (Consejo Superior de Investigaciones Cientı´ficas,
CSIC; approval number SAF2011–25608).
Animals were housed in temperature (2262uC) and light (12:12
light-dark cycle; lights on at 7 a.m.) controlled conditions and had
free access to food and water. Experiments involving comparisons
between genotypes were from the strains of mice described
elsewhere [6]. For the effects of dexamethasone (DEX) and
retinoic acid (RA) we used cultures derived from mice of the
C57BL/6J strain.
Pregnant dams were euthanized with CO2 on gestation day
17.5, and the fetuses were extracted and euthanized by
decapitation. The cerebral cortices were dissected at in PBS
containing 1% BSA and 0.1% Glucose. The tissue was disaggre-
gated by enzymatic digestion with 0.4 mg/ml Papain (Roche) and
passing through a 0.9-mm syringe in the presence of DNAse I.
The homogenate was centrifuged and the cells were resuspended
in serum free culture medium (Neurobasal Medium supplemented
with 2% B27, Glutamax, 10 U/ml Penicillin, and 10 U/ml
Streptomycin). The cells were seeded on poly-L-ornithine-coated
12-well multiwells (Sigma). The wells were previously preincubat-
ed with a mixture of Horse Serum and culture medium (1:1), and
Laminin (1 mg/ml) (Sigma). Cells were added to this media in
culture medium (66105 cells per well). After 9 days, the cells were
incubated 24 h in the same medium without B27 supplement
before adding the different treatments: 1 nM T3, 1 mM RA, or
10 nM DEX. Incubation times are indicated in the figure legends.
Control cultures without treatment were incubated in parallel. To
examine the response to T3 in the presence of inhibition of protein
synthesis, cycloheximide (CHX, Sigma) was added to the cultures
at a concentration of 8 mg/ml 30 min before T3 (10 nM) and the
cells were harvested 6 hours after T3 addition.
The composition of the primary cultures was analyzed by
immunofluorescence as follows: Cells plated on glass coverslips
were fixed with absolute acetone for 7 min at 220uC. After
permeabilization for 5 min in 0.5% Triton X-100 in PBS, the cells
were incubated for 1 h in 1% BSA 2% cold fish skin gelatin
(Sigma) 0.05% Triton X-100 in PBS to block non-specific
antibody binding sites. For immunofluorescence labeling, the cells
were stained by overnight incubation at 4 C in the blocking buffer
with the following combination of primary antibodies dilut-
ed1:500: monoclonal anti glial fibrillary acidic protein (Clone G-
A-5, Sigma) for astrocytes and rabbit polyclonal anti-NeuN [23]
(Millipore) for neurons. The secondary antibodies were donkey
anti mouse Alexa 488 (green) and donkey anti rabbit Alexa 555
(red) and were used at 1:500 dilution. Cells were then washed in
PBS and incubated for 10 min with 49,6-diamidino-2-phenylin-
dole (DAPI, GibcoH Life Technologies) 0.1 mg/ml in PBS to label
the nucleus. Omitting the first antibodies in the incubation
reaction gave no signal. Confocal images were acquired using an
inverted Zeiss LSM 710 laser scanning microscope with a plan-
apochromatic objective 636/N.A 1.3. Sequential scanning mode
was used to avoid crosstalk between channels. All images shown
correspond to the maximum intensity projection of a z-stack.
Images were processed with Zen 2009 software and Adobe
Photoshop (Figure S1). To calculate the relative abundance of
neurons and astrocytes in the different cultures antibody-labeled
cells and DAPI-stained nuclei were counted in photographs taken
using a 406 objective. A total number of 100–200 cells were
counted in sextuplicate for each culture. The relative number of
neurons and astrocytes were calculated as a percentage of DAPI-
stained nuclei. The results are presented in Table S1. These
cultures are enriched in neurons and there were no differences in
the % cells stained as neurons in the three cultures. The %
astrocytes were slightly higher in the TRa12/2 and the TRb2/2
than in the Wt, although only statistically significant when
comparing Wt and TRa12/2. As in other studies [24] less than
10% of the cells were not stained as astrocytes or neurons.
Total RNA was isolated using the Trizol procedure (Invitrogen,
Carlsbad, CA). 250 ng RNA was used as template for the cDNA
synthesis with the high-capacity cDNA reverse transcription kit
(Applied Biosystems, Foster City, CA). PCR assays were
performed using SYBR Green or TaqMan assays (Applied
Biosystems) on a 7900 HT fast real-time PCR system. The PCR
program consisted in a hot start of 95uC for 10 min, followed by
40 cycles of 15 s at 95uC and 1 min at 60uC. Expression of RARb,
RXRa and Cyp26b1 was measured using SYBR Green quantitative
PCR with the following primers: RARb forward
59GTGGGCATGTCCAAAGAGTC39; RARb reverse
59GCTCCGCTGTCATCTCATAG39; RXRa forward
59CCGCTCCATAGCTGTGAAAG39; RXRa reverse
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59CTGTTAGCACCCTGTCAAAG39; Cyp26b1 forward 59TA-
CAGGGTTCCGGCTTCCAG39; Cyp26b1 reverse
59GCACCGGTCACACGAATCAG3. For analysis we used the
2-Ct method. For internal control RNAs we compared 18S RNA
and Cyclophylin (Ppia) mRNA. Either control gave similar results
(Figure S2). For the final calculations the data were corrected for
18S RNA and expressed relative to the value obtained for the
control cells, which was given a value of 1.0.
To calculate significance of differences between means we used
one- or two-way ANOVA, or two-tailed, unpaired Student’s t-test
depending on the experiments. Calculations and graphics were
performed using the GraphPad Prism software (www.graphpad.
com/prism/).
Results
The goal of this work was to analyze the effect of T3 on gene
expression in cerebrocortical primary cultures. As T3 targets we
selected genes previously known to be thyroid hormone dependent
in brain, and that likely play a prominent role in mediating the
effects of thyroid hormones on neural development, as follows: 1)
the transcription factor and T3 receptor co-repressor Hr (Hairless),
which was originally shown to be under transcriptional regulation
by T3 in the cerebellum [25]. Hr has since then been a widely
studied T3 target to analyze the effects of thyroid hormone on the
brain. 2) The developmental morphogen Shh (Sonic hedgehog),
which is regulated by thyroid hormone in the rat and mouse
embryonic and adult brain, presumably at the transcriptional level
[26]. 3)The transcription factor Klf9 (Kru¨pfel-like transcription
factor 9, also known as Basic Transcription Element Binding
Protein or BTEB), which is regulated by thyroid hormone at the
transcriptional level during tadpole metamorphosis, oligodendro-
cyte differentiation, and in the rodent brain [27]. 4) Dio3, which is
regulated specifically by TRa1 [28]. 5) Aldh1a1 (Aldehyde
dehydrogenase 1a1), a gene sensitive to hypothyroidism produced
by blocking thyroid hormone formation, but not by brain
hypothyroidism resulting from Mct8 and Dio2 inactivation, as
explained in the Introduction [5]. 6) Aldh1a3, a gene negatively
Figure 1. Effect of T3 on gene expression in primary mouse cerebrocortical cell cultures in the presence or absence of TRa1 or TRb.
Cells (n = 6) from wild type (Wt), TRa1 KO (aKO), or TRb KO (bKO) mice were incubated for 24 hours in the absence (open bars) or in the presence of
1 nM T3 (filled bars). Statistical analysis was by two-way ANOVA; ns = P.0.05; * = P,0.05; ** = P,0.01; *** = P,0.001.
doi:10.1371/journal.pone.0091692.g001
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regulated by T3 [29], which participates in the same retinoic acid
synthesis pathway as Aldh1a1 [30]. To search for clues that may
explain the puzzling behaviors mentioned above we analyzed the
thyroid hormone receptors subtypes specificity and also the effects
of other factors such as retinoic acid, and glucocorticoids and their
interactions with T3.
The relative role of receptor subtypes in the gene responses to
T3 is illustrated in Figure 1. For this experiment we isolated E17.5
cerebrocortical cells from Wt mice, TRa1 KO mice, and TRb
KO mice. Gene expression was measured in the absence of T3,
and 24 h after addition of 1 nM T3 to the cultures. In previous
experiments (not shown) we found that increasing the T3
concentration up to 100 nM did not increase the response above
that attained with 1 nM T3. As an experimental control of the
effect of receptor inactivation we measured the expression of Dio3
(encoding the type 3 deiodinase), which is regulated by T3 in a
TRa1 isoform-specific way. Dio3 expression in cells lacking TRa1
or TRb was similar to Wt cells in the absence of T3. Addition of
T3 increased Dio3 expression by 4-fold in the Wt cells, and had no
effect on the TRa1-deficient cells. TRb deficiency potentiated the
effect of T3, with an 8-fold induction, to twice the level obtained in
the Wt cells. From the rest of the genes studied, only Aldh1a1 was
unresponsive in cells deficient of TRa1. T3 increased Aldh1a1
expression in the Wt cells, but had no effect on the TRa1-deficient
cells. In the TRb-deficient cells the basal expression of Aldh1a1 in
the absence of T3 was increased with respect to the untreated Wt
cells, and was further increased by T3.
Hr, Klf9, and Shh showed no TR isoform specificity, and were
induced by T3 in the three culture types. Hr and Shh were induced
by 5-fold and 6-fold, respectively in Wt cells and about 2-fold in
the TRa1-deficient cells. Similarly Klf9 increased 2-fold after T3
addition to the Wt cells and 1.3-fold in the TRa1-deficient cells. In
the TRb-deficient cells T3 induced a similar effect as in the Wt
cells on Shh, but the effects on Hr and Klf9 were increased.
The Aldh1a1 enzyme is involved in RA synthesis, catalyzing
conversion of all-trans-retinal to all-trans-retinoic acid. Another
aldehyde dehydrogenase Aldh1a3 is also involved in this pathway.
In contrast to Aldh1a1, Aldh1a3 is negatively regulated by T3
(Figure 1), with a 40% reduction after T3 addition to the Wt cells.
TRa1-deficient cells behave exactly as the Wt cells. In the absence
of TRb the basal expression increased by about 60% and T3
induced a similar effect as in the Wt cells.
To check whether the effects of T3 were due to a direct action
on gene transcription, or mediated through increased expression
of T3-dependent auxiliary proteins or transcription factors, we
analyzed the effect of T3 in a shorter time, in the presence of the
protein synthesis inhibitor CHX (Figure 2). After 6 hours in the
presence of T3 an increased expression of Hr, Klf9, and Shh was
already observed. The effect on any of these genes was not blocked
by CHX pretreatment, indicating a direct effect of T3 on these
genes. In contrast T3 had no significant effects on Dio3, Aldh1a1
and Aldh1a3 at 6 hours. Therefore no conclusions about the
mechanism of induction could be made for Dio3 and Aldh1a1.
CHX had a strong stabilizing effect on Aldh1a3 mRNA, and in the
cells pretreated with CHX T3 was able to reduce Aldh1a3
expression, suggesting that also for this gene the effect was direct.
Since Aldh1a1 and Aldh1a3 are involved in RA synthesis we
analyzed the effect of RA and a possible synergism with T3. As
controls for the effects of RA we measured the expression of two
RA-target genes, the RA receptor b, RARb and the RA degrading
enzyme Cyp26b1 (Figure 3) [31]. RARb was increased by RA but
not by T3. When added together the presence of T3 inhibited the
effect of RA. Interestingly we found that Cyp26b1 was positively
regulated by T3, with an effect quantitatively similar to that
obtained with RA. There was no additive effect when both agents
were added together. The relative effects of RA and T3 on Aldh1a1
were a mirror image of those on RARb. Aldh1a1 was increased by
T3 but without effect of RA, but RA inhibited the effect of T3
when added together. Aldh1a3 was down regulated by T3 and
there was no effect of RA.
Many thyroid hormone regulated genes are also influenced by
glucocorticoids, and in some instances there is synergism between
the two hormones. Among the genes analyzed in this work, it is
known that Klf9 in tadpoles is synergistically regulated by T3 and
glucocorticoids at the transcriptional level. Indeed we found that
also on Wt cerebrocortical cells (Figure 4) DEX stimulated Klf9
expression, similarly to T3, and there was a synergistic effect when
both hormones were added together. Aldh1a1 expression was also
stimulated by dexamethasone, in addition to T3. In the presence
of both hormones there was a strong synergistic effect of T3 and
DEX and Aldh1a1 expression was increased 20-fold. To explore
possible mechanisms for the interaction between T3 and DEX we
measured the effect of DEX on the TR heterodimeric partner
RXRa, as it has been reported that DEX increases the expression
of RXRa [32]. Indeed we found that DEX increased RXRa
expression (Figure 4), but not RXRc (not shown). In TRa1-
deficient cells T3 and DEX also stimulated Klf9 expression, as was
expected due to lack of receptor specificity. However and in
agreement with the previous finding, TRa1 was needed for the
effect of T3 on Aldh1a1 expression, since the response to T3 in cells
derived from TRa1 KO mice was suppressed, whereas the
response to DEX was maintained. Although T3 alone had no
Figure 2. Effect of T3 in the presence or absence of
cycloheximide (CHX) on gene expression in primary mouse
cerebrocortical cell cultures from wild type mice. The cells (n = 4)
were incubated for 30 min with or without CHX (8 mg/ml) before
adding T3 (10 nM), and then incubated for 6 hours. Statistical analysis
was by one-way ANOVA; ns = P.0.05; * = P,0.05; ** = P,0.01; *** = P,
0.001.
doi:10.1371/journal.pone.0091692.g002
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effect in the absence of TRa1, it increased the response to
dexamethasone.
Among the possible mechanisms by which T3 potentiates the
effect of DEX in the absence of TRa1, is an increased expression
of the glucocorticoid receptor. To test this hypothesis we measured
the effect of T3 on the glucocorticoid receptor mRNA Nr3c1 in Wt
cells and in TRa1-deficient cells (Figure 4). In both types of cells
T3 increased Nr3c1 expression by 30–50%. DEX alone decreased
Nr3c1 expression by 25%, but not when added together with T3.
The effect of T3 was not observed at shorter times of incubation,
i.e., 6 hours, and we cannot conclude that it is a direct action of the
hormone (not shown).
Discussion
In this work we have analyzed the contribution of factors others
than T3 itself, that might be involved in the regulation of gene
expression and that may play diverse roles in vivo. This experi-
mental set up allowed us to confirm that genes which expression in
the mouse cerebral cortex [6] is strongly dependent on thyroid
hormones are indeed cellular targets of T3. The altered expression
previously observed in vivo after induction of hypothyroidism was
not due to a distal effect of the hypothyroid condition, but reflected
a cellular effect of the hormone. The cellular system employed in
this work is based on the culture of primary cells isolated from the
embryonic mouse brain. These cultures are enriched in neurons
but also contain astrocytes and unidentified cells (Table S1, Figure
S1 and [24]). Therefore any effect observed by hormonal
manipulations of these cells could have its origin in neurons or
in astrocytes, depending among other factors on the relative
expression of the target gene in each of these cell types.
First we analyzed the specific contribution of the TRa1 and
TRb receptor subtypes by measuring the response to T3 of
primary cells derived from the cerebral cortex of TRa1 and TRb
KO mice. The results confirm [6] that at the cellular level both
TRa1 and TRb mediate the effects of T3, with two exceptions,
Dio3 and Aldh1a1. Dio3 was already shown to be regulated
specifically by TRa1 [28], and we confirm this fact in the cultured
neurons. Also Aldh1a1 appears to be regulated specifically by
TRa1, since no induction by T3 was observed in cells derived
from TRa1 KO mice. Klf9 and Aldh1a3 show no preference for
each of the TR subtypes. A recent global analysis of TR specificity
in HeLa cells expressing exogenous TRa1 or TRb1 [33]
concluded that there are no complete TR subtype specificity,
although TRa1 or TRb1 showed some gene preferences,
depending on the time of exposure and the dose of T3. In
established neural cell lines expression TRa1 or TRb1 lead to
substantial differences in the gene network regulated by T3,
without correlation with differential chromatin occupancy [34].
Direct transcriptional regulation by T3, has previously been
shown for Hr [25], Klf9 [27,35] Dio3 [28], and Shh [26].
Chromatin occupancy by the TR has been shown for Hr and
Klf9 in established neural cell lines [34]. Here we confirm that also
in cerebrocortical primary cells Hr, Klf9, and Shh are direct
transcriptional targets of T3, given that the effect of the hormone
was not blocked by previous treatment with CHX to inhibit
protein synthesis. We could not determine whether Dio3 was also
transcriptionally regulated by T3 because it was not stimulated by
T3 at 6 hours of incubation, preventing to test the effect of CHX.
However, a specific TRa1 binding site has been demonstrated in
the upstream region of the gene [28]. The fact that we could not
determine whether the effect of T3 was direct, suggest the
possibility that the full effect of T3 requires interaction with other
intermediate proteins. Dio3 is a transcriptional target of Shh [36]
which, as mentioned above is a direct T3 target. This raises the
possibility that rapid and full induction of Dio3 by T3 is the result
Figure 3. Effects of T3 and all-trans retinoic acid (RA) on gene expression in primary mouse cerebrocortical cell cultures from wild
type mice. The cells (n = 4) were incubated for 48 hours in the absence or presence of T3 (1 nM), RA (1 mM) or both. Statistical analysis was by one-
way ANOVA; ns = P.0.05; *** = P,0.001.
doi:10.1371/journal.pone.0091692.g003
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of a direct transcriptional effect of TRa1 potentiated by the T3-
dependent accumulation of Shh protein.
A relevant new finding is the influence of T3 on the expression
of genes involved in the synthesis and degradation of RA. We had
previously observed a reduction of Aldh1a1 expression in the brain
of hypothyroid mice. By stimulating Aldh1a1 expression T3 would
increase RA synthesis. However, this effect would be counteracted
by down regulation of Aldh1a3 acting in the same pathway, and by
up regulation of Cyp26b1, a gene encoding a RA degrading
enzyme. During development Aldh1a3 expression is maximal at
E14, and decreases to very low levels near birth, whereas Aldh1a1
rises postnatally in the telencephalon [37]. It is likely that these
changes of expression are influenced by the thyroid hormone
concentrations and TR expression changes occurring during
development. In addition to this bulk effect, the net effect of
thyroid hormone on RA production should depend on the relative
expression of each enzyme in specific brain regions. Since the
effect of T3 on Aldh1a1 expression is TRa1 dependent, the net
effect of T3 in specific cells would depend on the relative
concentrations of TRa1 and TRb. Aldh1a1 is involved in the
regulation of the total number of dopaminergic neurons [38] and
in the metabolism of dopamine and norepinephrine [39]. Aldh1a3
is expressed in the ganglionic eminence where RA and thyroid
hormone influence tangential neuronal migrations leading to the
generation of cerebral cortex interneurons [40,41]. These effects
are likely to be important in the regulation of developmental
events by T3.
The effect of T3 on Aldh1a1 expression is also sensitive to RA.
Although at the doses used RA in isolation does not influence
Aldhla1 expression, it inhibits the effect of T3. On the contrary, the
RARb response to RA is reduced by the presence of T3. Cyp26b1,
which is sensitive to RA and T3, does not show an additive effect
in the presence of both compounds, which might also be due to
mutual interference. In this respect it is likely that the combined
responses to RA and T3 are modulated by COUP-TF1, which is
widely expressed in the nucleus of primary neurons (unpublished
results from our laboratory). In neurons derived from embryonic
stem cells COUP-TF1 represses T3 induction of the T3 target
gene Camk4 and confers RA sensitivity. This effect is mediated
through a regulatory element containing overlapping binding sites
for TR, RAR, and COUP-TF1 [13].
In our primary cultures Klf9 and Aldh1a1 expression were
increased by DEX which also potentiated the effects of T3. Klf9 is
induced by corticosterone in the tadpole brain and in the Xenopus
Figure 4. Effects of T3 and dexamethasone (DEX) on gene expression in primary mouse cerebrocortical cell cultures from wild type
mice or from TRa1 KOmice. The cells (n = 4) were incubated for 48 hours in the absence or presence of T3 (1 nM), DEX (10 nM) or both. Statistical
analysis was by one-way ANOVA; ns = P.0.05; * = P,0.05; ** = P,0.01; *** = P,0.001.
doi:10.1371/journal.pone.0091692.g004
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laevis fibroblast cell line XTC-2, and is proposed to mediate effects
of glucocorticoids on neuronal structure and function [22]. To the
best of our knowledge, Aldh1a1 was not known to be induced by
glucocorticoids. DEX had an effect comparable to that of T3. But
when added together there was a synergistic effect and Aldh1a1
expression increased by 20-fold, the largest increment effected by
T3 that we have knowledge on any gene in neural cells.
A summary of the crosstalk between T3, RA and glucocorticoid
signaling, as described in the present work is illustrated in Figure 5.
These interactions are likely to be operating in different cell
population micro domains at different stages of development. The
net result would be a function of the expression of the different
components present in the figure as the cells undergo their
differentiation program.
Supporting Information
Figure S1 Confocal images of the cerebrocortical cul-
tures from Wt, TRa1KO and TRbKo mice. Upper panels:
Cells stained with antibodies against GFAP and NeuN. Lower
panels: Nuclei stained with DAPI. Scale bar = 25 mm.
(TIF)
Figure S2 Correlation between qPCR measurements
using as internal control 18S RNA or Cyclophylin RNA
(Ppia). Correlation coefficient was 0.95, P,0.0001.
(TIF)
Table S1 Cellular composition of the cerebrocortical primary
cultures. Shown are the percentage of neurons and astrocytes
relative to the total number of DAPI-stained nuclei. Data are
mean 6 SD (n = 6), and 95% Confidence Interval (CI). (*): P,
0.05 compared to Wt. Other comparisons were not significant.
(DOCX)
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